Search - tctmd.com

Displaying 141 - 160 of 717

Sort: Relevancy | Date

Presentation NY Valves 2025

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

Presenter: Erwan Donal

June 25, 2025

Presentation NY Valves 2025

TAV-in-TAV-in-SAVR After M-TEER: A Complex Case Breakdown: The Matryoshka Doll Effect

Presenter: Silvia Corona

June 25, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation NY Valves 2025

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Presenter: Philipp von Stein

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2025

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

GDMT in FMR: What Every Interventionalist Needs to Know

Presenter: Sean P. Pinney

June 25, 2025

Presentation NY Valves 2025

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2025

Structuralist Viewpoint

Presenter: Ralph Stephan von Bardeleben

June 25, 2025

Presentation NY Valves 2025

Surgical Viewpoint

Presenter: Michael A. Borger

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Nino Mihatov

June 25, 2025

Presentation NY Valves 2025

Holographic Imaging in the Real World: Precision Guidance in M-TEER

Presenter: Maria Ivannikova

June 25, 2025

Presentation NY Valves 2025

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

Presenter: Konstantinos P. Koulogiannis

June 25, 2025

Presentation NY Valves 2025

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

Presenter: Sam Dawkins

June 25, 2025

Presentation NY Valves 2025

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Presenter: Arnar Geirsson

June 25, 2025

Presentation NY Valves 2025

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

Presenter: Nino Mihatov

June 25, 2025

Presentation NY Valves 2025

3D Echocardiography for MR Anatomy: Surgical vs M-TEER Feasibility

Presenter: Vratika Agarwal

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

Advertisement

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

TAV-in-TAV-in-SAVR After M-TEER: A Complex Case Breakdown: The Matryoshka Doll Effect

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

How Do I Assess the Mechanism and Severity of MR After M-TEER?

GDMT in FMR: What Every Interventionalist Needs to Know

Phenotyping of FMR: Imaging Classification, Severity Assessment, and Parameters for Futility

Case Presentation: A Symptomatic Patient With Moderate to Severe MR

Structuralist Viewpoint

Surgical Viewpoint

Case Resolution

Holographic Imaging in the Real World: Precision Guidance in M-TEER

The Imager Perspective: Can Imaging Insights Determine Optimal Treatment Strategy?

The Structuralists Perspective: Why Not Try Mitral TEER First? (Surgery Can Always Be a Later Option)

The Mitral Surgeon’s Perspective: High Risk Surgery is Better than Sub-Optimal Mitral TEER!

Case Presentation: Primary MR in a High-Surgical Risk Patient with “Yellow-Zone” Anatomy

3D Echocardiography for MR Anatomy: Surgical vs M-TEER Feasibility

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content